Who has invested in Alys Pharmaceuticals?

Medicxi are named among the investors backing Alys Pharmaceuticals.

Alys Pharmaceuticals Funding: $100M Raised, Seed (2024)

Alys Pharmaceuticals funding overview

Alys Pharmaceuticals is based in Lausanne, Switzerland. Alys Pharmaceuticals has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Seed announced in February 2024. The round record for Alys Pharmaceuticals runs through 2024; nothing later has been disclosed. Investors on record include Medicxi.

Alys Pharmaceuticals at a glance

Total raised: $100M
Latest round: Seed
Latest round date: February 2024
Headquarters: Lausanne, Switzerland
Notable investors: Medicxi

Frequently asked about Alys Pharmaceuticals funding

How much has Alys Pharmaceuticals raised?: Alys Pharmaceuticals has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Alys Pharmaceuticals?: Medicxi are named among the investors backing Alys Pharmaceuticals.
What was the latest Alys Pharmaceuticals funding round?: The most recent disclosed round is a Seed, announced in February 2024.
Where is Alys Pharmaceuticals based?: Alys Pharmaceuticals is based in Lausanne, Switzerland.
When did Alys Pharmaceuticals last raise?: The last disclosed Alys Pharmaceuticals round closed in February 2024 at Seed.

Alys Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Lausanne below to benchmark round size and investor mix.

Alys Pharmaceuticals Funding: $100M Raised, Seed (2024)

Alys Pharmaceuticals funding overview

Alys Pharmaceuticals at a glance

Frequently asked about Alys Pharmaceuticals funding

Companies related to Alys Pharmaceuticals (28)

Browse related funding lists (4)